Semax
Semax
Semax: Semax is an ACTH-derived seven-residue peptide. Israel sizes and COAs; quote-only laboratory catalog.
CAS 80714-61-0

Compound information
- Compound identity
- Semax
- CAS number
- 80714-61-0
- Molecular formula
- C37H51N9O10S
- Molecular weight
- 813.9 g/mol
Reference values describe the named chemical form. Consult the lot-specific report for the material supplied.
Vial sizes and availability
- 10mg · Price on request · In stock · estimated dispatch Local dispatch requires confirmation · Select 10mg
Material identity and evidence limits
Semax is an ACTH-derived seven-residue peptide. It is distinct from Selank; findings in a specified experimental model do not establish improved focus in people.
Semax research: identify the experimental model
Semax is described as Met-Glu-His-Phe-Pro-Gly-Pro, also written ACTH(4–7)PGP. The full sequence and chemical form matter when matching a publication to a material; the shared word “peptide” or a cognitive-research category is not an identity test.
Sudarkina and colleagues’ 2021 primary study used male Wistar rats with experimental cerebral ischemia–reperfusion. It examined four proteins in different brain regions 24 hours after artery occlusion. Changes in protein expression are mechanistic observations, not a demonstrated focus or memory benefit in healthy people.
The authors identify the limited protein set as a study limitation. This experiment did not test this catalog lot or a finished nasal spray. A laboratory vial and a formulated product are different specifications; a paper cannot replace batch-specific identity, content or formulation evidence. This is not a mixing or administration protocol.
Certificates of analysis
Certificates of analysis · COA Library · Research purchaser requirements
Match the full compound identity, size and lot to the original report. Availability and purchaser eligibility must be confirmed before fulfillment.
Browse all compounds · Compound reference index · How to read a COA